There is a moment when public health stops being public health and becomes reputation management for old mistakes.
That is where we are with wireless radiation.
The UK government has now repeated the same tired institutional script on electromagnetic hypersensitivity: symptoms are real, suffering may be disabling, but do not connect that suffering to electromagnetic fields. UKHSA cites WHO, SCHEER, and AGNIR, then says the reviews suggest symptoms reported by people with EHS are “not directly related” to electromagnetic fields. It repeats WHO’s line that EHS has no clear diagnostic criteria and no scientific basis linking symptoms to EMF exposure.
That is not science settled.
That is science stalled.
A lack of diagnostic criteria is not proof that a condition is imaginary. It is proof that the medical system has not built the right diagnostic framework. In every other field of modern medicine, when crude testing fails, serious scientists improve the test. They stratify patients. They look at genetics, physiology, sleep, autonomic tone, inflammation, mitochondrial reserve, exposure timing, delayed response windows, and vulnerable subgroups.
But with EHS, WHO and its aligned agencies do the opposite. They take the failure of narrow provocation studies — “can this person consciously detect when the router is on?” — and turn that into a sweeping public-health dismissal.
That is the central fraud in the EHS debate.
Humans are not dosimeters. Humans are not perfect RF meters. Humans are dynamic, genetically diverse, state-dependent biological control systems. A person can fail to consciously detect a signal and still have measurable changes in sleep EEG, autonomic function, calcium timing, mitochondrial redox state, gene expression, immune signaling, or symptom cascades hours later.
The old model tested perception.
The new model must test physiology.
And that is exactly what WHO, ICNIRP, and their government allies keep refusing to do.
The WHO–ICNIRP Loop
To understand the denial machine, you have to understand the loop.
ICNIRP presents itself as an independent scientific commission. It is registered in Munich as a nonprofit organization and is formally recognized by WHO and ILO as an official collaborating non-state actor. WHO then points governments toward exposure norms based on ICNIRP-type limits and says that exposures below international guideline limits do not appear to have known health consequences.
Then governments repeat it.
UKHSA says central to its advice is compliance with ICNIRP guidelines. It says public exposures are typically well below those guidelines. It notes that industry has voluntarily committed to comply with them, and that Ofcom has made compliance with ICNIRP guidance a spectrum-license condition.
That is the pipeline.
ICNIRP defines the safety frame. WHO legitimizes the safety frame. Governments adopt the safety frame. Industry complies with the safety frame. Then the public is told the matter is settled because everyone agrees with the safety frame.
But the frame itself is the problem.
ICNIRP’s 2020 RF guidelines claim to protect against all substantiated adverse health effects from radiofrequency EMFs, including 5G. That is an enormous claim. It is also the exact claim now under pressure from animal cancer data, reproductive-toxicity data, the FCC court remand, FDA’s own non-thermal RF medical-device record, and new mechanistic evidence involving calcium-channel and mitochondrial signaling.
This is not independent public-health protection.
This is a closed global doctrine.
Capture Does Not Need a Smoking Gun
Institutional capture does not always look like a suitcase of cash in a dark room. Often it looks cleaner than that.
It looks like a small circle of experts defining the acceptable assumptions, writing the guidelines, reviewing the evidence that challenges those guidelines, participating in WHO-linked processes, and then appearing again as the authorities governments cite to reassure the public.
ICNIRP’s own pages list Ken Karipidis as Vice-Chair and Dan Baaken as Scientific Secretary and Board member for the 2024–2028 period. ICNIRP working-group pages also list overlapping experts, including Karipidis and Sarah Loughran, in RF-related working structures.
That does not, by itself, prove misconduct.
But it absolutely proves the need for conflict disclosure, independent weighting, and outside review.
A 2025 critique by Melnick, Moskowitz, and ICBE-EMF argues that WHO-commissioned RF systematic reviews contain methodological problems and that the longstanding WHO–ICNIRP relationship creates influence concerns that must be confronted, not ignored.
That is the point. The public does not need another insider review telling us the insiders were right.
The public needs an independent risk assessment that does not begin with the conclusion that ICNIRP must be defended.
The Evidence That Breaks the Thermal-Only Story
For decades, wireless radiation policy has been trapped inside a primitive assumption: if RF exposure does not heat tissue beyond a prescribed limit, then it is not a serious public-health problem.
That assumption is no longer defensible.
The National Toxicology Program found clear evidence of an association between high exposure to cell-phone radiofrequency radiation and malignant schwannomas of the heart in male rats, some evidence for malignant gliomas in male rats, and DNA-damage associations in certain tissues. NTP also made clear that the studies were designed to test whether RFR could cause biological effects at exposure levels that did not significantly raise body temperature, and heating was limited to less than 1°C.
That matters. The standard dismissal — “the exposures were high” — is not enough. High compared with typical whole-body human exposure does not mean irrelevant. The key question is whether the findings fit a simple heating artifact. They do not.
Then the federal research program retreated. NTP says its follow-up exposure system was technically challenging, resource intensive, and not representative of newer technologies such as 4G, 4G-LTE, or 5G, and that no further work with that RFR exposure system will be conducted.
That is not a resolution.
That is abandonment at the exact moment when the law requires modernization.
The WHO-partially-funded Mevissen systematic review of RF animal cancer evidence included 52 studies and reported high certainty of evidence for glioma in male rats and high certainty for malignant heart schwannomas in male rats, while properly noting that extrapolating animal bioassays to human RF risk is complex.
Then Ronald L. Melnick and Joel M. Moskowitz applied benchmark-dose and risk-assessment methods to animal cancer and reproductive data. Their 2026 Environmental Health paper concluded that current public whole-body FCC/ICNIRP-type limits are 15- to 900-fold higher than their estimated levels associated with a 1-in-100,000 cancer risk, depending on exposure duration, and 8- to 24-fold higher than levels they estimate would protect male reproductive health.
That is the paper regulators cannot wave away with another “nothing to see here.”
It does not mean every question is settled. It means the old basis for inaction is broken.
The FCC Already Lost the Legal Argument
The courts have already recognized the regulatory failure.
In 2021, the D.C. Circuit remanded the FCC’s decision to keep its 1996-era RF exposure limits unchanged. The court found that the FCC failed to provide a reasoned explanation for its conclusion that its guidelines adequately protect against harmful effects unrelated to cancer. The court specifically faulted the agency for failing to address non-cancer evidence, children, long-term exposure, RF pulsation and modulation, technological developments since 1996, ubiquity of wireless devices, and environmental impacts.
This is devastating because the FCC is not a medical agency.
The FCC auctions spectrum. It licenses communications infrastructure. It is not a toxicology agency, not a pediatric health agency, not a cancer-risk agency, not a reproductive-health agency, and not an environmental-medicine agency.
So when the FCC hides behind FDA or WHO statements, the question becomes unavoidable: where is the medical risk assessment?
Where is the HHS-led biological review?
Where is the modern federal evaluation of chronic exposure, pulsed modulation, children, pregnancy, fertility, cancer, neurological effects, sleep, and non-thermal mechanisms?
The answer is: it has not been done at the level required by the law, the science, or the court.
The FDA’s Own Files Break the ICNIRP Myth
Here is the part ICNIRP can never explain away.
FDA authorized the TheraBionic P1 under a Humanitarian Device Exemption for advanced hepatocellular carcinoma. FDA describes the device as a handheld RF electromagnetic-field generator that emits specific amplitude-modulated frequencies and may stop cancer cells from dividing.
FDA’s Summary of Safety and Probable Benefit describes low-level amplitude-modulated RF EMFs, systemic absorption, no thermal heating in the brain or other organs, and delivered EMF levels estimated to be 100 to 1,000 times lower than those delivered by cellular phones. The same FDA record says the device should not be used in patients receiving calcium-channel blockers or agents blocking L-type or T-type voltage-gated calcium channels unless treatment is modified.
Published mechanistic work on amplitude-modulated 27.12 MHz RF EMF treatment in hepatocellular carcinoma models describes the exposure as athermal and lower than cell-phone levels, and reports involvement of calcium influx through CaV3.2 T-type voltage-gated calcium channels encoded by CACNA1H.
That does not prove that a cell phone is the same as TheraBionic.
That is not the argument.
The argument is much more precise: FDA has already accepted that low-level, non-thermal, amplitude-modulated RF can be biologically meaningful in a regulated medical-device context.
So the public-health question becomes obvious:
If tuned RF can interact with calcium-channel biology in medicine, why are chronic, involuntary, untuned, pulsed consumer and infrastructure exposures treated as biologically irrelevant by default?
That one question breaks the thermal-only doctrine.
The Mechanisms Are No Longer Vague
The denial machine keeps pretending that non-thermal RF biology is just a pile of anecdotes.
It is not.
A 2025 randomized, double-blind, sham-controlled NeuroImage study found that 3.6 GHz 5G RF-EMF modulated NREM sleep-spindle center frequency in a CACNA1C genotype-dependent manner. CACNA1C encodes the alpha-1C subunit of the L-type voltage-gated calcium channel. The study did not prove harm. It did not prove EHS. But it did show that a defined RF exposure can shift an objective human brain rhythm differently depending on genotype.
That is the doorway.
A 2026 Cell paper reported an electromagnetic-field-inducible gene-switch system and identified CYB5B as an essential mediator, with EMF-specific calcium oscillations central to activation. Again, that does not prove ordinary wireless exposure causes disease. But it does identify a concrete biological node for testing EMF-to-calcium-to-gene-expression coupling.
Mechanistic literature has also proposed that weak-field interactions may involve voltage-gated ion-channel timing, calcium disturbance, mitochondrial redox pathways, nitric-oxide signaling, ROS, and oxidative stress.
This is where the debate must move.
Not “does RF cook tissue?”
Not “can a person guess when the router is on?”
The real question is whether modern wireless emissions — pulsed, modulated, polarized, coherent, variable, beamformed, and emitted from multiple simultaneous sources — can degrade biological signaling fidelity in vulnerable tissues and vulnerable people.
That is testable.
And because it is testable, regulators have no excuse for pretending the question does not exist.
EHS Is Not Refuted by a Bad Test
WHO and UKHSA’s EHS position is especially revealing.
They say there are no clear diagnostic criteria and no established scientific basis linking symptoms to EMF exposure. But that is not a scientific endpoint. That is an admission of diagnostic failure.
The old provocation model asked whether self-identified EHS patients could consciously detect short active-versus-sham exposures. That is a legitimate question, but it is not the full biological question.
A person can have objective physiology without conscious perception.
Sleep architecture does not need permission from conscious awareness. Calcium oscillations do not need a person to say “the router is on.” Mitochondrial redox state does not require a symptom to appear in the first five minutes. Gene-expression timing, immune signaling, autonomic arousal, and delayed symptom windows do not operate on the schedule of a crude provocation study.
The next-generation EHS study should be genotype-stratified, double-blind, sham-controlled, and built around objective endpoints: sleep EEG, NREM spindle frequency, HRV, pupillometry, skin conductance, blood pressure, microarousals, symptom tracking over 2–72 hours, personal RF/ELF dosimetry, and patient-derived cellular assays.
The model is not “EMF bad.”
The model is: defined waveform, susceptible receiver biology, vulnerable physiological state, measurable timing disruption, and symptom coupling in some individuals.
That is precision physiology.
And it is exactly the kind of science WHO should be demanding instead of suppressing.
President Trump Was Right to Leave WHO
President Trump’s withdrawal from WHO was officially tied to WHO’s COVID-19 failures, failure to adopt reforms, inability to demonstrate independence from inappropriate political influence, and the disproportionate financial burden carried by the United States. HHS and State announced completion of the U.S. withdrawal on January 22, 2026, after Trump announced the plan on January 20, 2025.
EHS was not the official reason.
But the EHS/RF issue shows the same disease.
A global health bureaucracy gets locked into an old position. It aligns with a narrow technical guild. It dismisses contrary evidence. It treats uncertainty as permission to reassure the public instead of permission to investigate. It protects institutional credibility before public health.
That is why leaving WHO was not merely symbolic.
It was a line in the sand.
America should not outsource public-health judgment to an organization that is still recycling outdated RF assumptions while modern biology, toxicology, and risk assessment are moving in the opposite direction.
And the UK should take notice. The UK can keep hiding behind WHO and ICNIRP, or it can start protecting its own people.
The FDA Crossroads
Now the FDA has its own test.
Reuters reported in January 2026 that HHS would launch a study on cellphone radiation and that FDA had taken down older webpages saying cellphones were not dangerous, even while other agency pages continued to say there was no credible evidence of health problems. FDA’s current public-facing cell-phone page still says the weight of scientific evidence has not linked cell-phone RFR with health problems and says the evidence does not show danger to children and teenagers.
That is the contradiction.
The old blanket reassurance script is cracking, but it has not yet been replaced with honest public-health language.
The FDA leadership fight now matters. Reuters reported that FDA Commissioner Marty Makary resigned on May 12, 2026, that Kyle Diamantas would temporarily lead the FDA, and that Stephen Hahn and Brett Giroir were among the names under consideration for permanent leadership. FDA’s own biography describes Diamantas as Deputy Commissioner for Food, leading the Human Foods Program. Hahn served as FDA commissioner from December 2019 to January 2021 and has a background in oncology and radiation oncology. Giroir served as Assistant Secretary for Health and briefly as acting FDA commissioner in 2019, with a background in pediatrics, critical care, and federal health leadership.
The issue is not whether these people have credentials.
They do.
The issue is whether the next FDA commissioner will finally enforce the radiation law, or whether FDA will keep treating wireless radiation as somebody else’s problem.
Congress Already Gave FDA the Law
Public Law 90-602 was not written for decoration.
The electronic product radiation-control provisions now codified in federal law require the HHS Secretary to establish and carry out a program to protect public health and safety from electronic product radiation. That program includes research, exposure evaluation, performance standards, and developing techniques to minimize unnecessary exposure. FDA also describes itself as responsible for regulating radiation-emitting electronic products, and federal definitions cover electronic products that contain electronic circuits and emit electronic product radiation.
That means FDA and HHS cannot credibly shrug while FCC keeps relying on 1996-era assumptions.
This is even more urgent because Section 704 of the Telecommunications Act bars state and local governments from regulating wireless facility placement based on the environmental effects of RF emissions when facilities comply with FCC rules.
That creates the perfect regulatory trap.
Local governments are gagged.
The FCC is not a medical agency.
WHO and ICNIRP keep repeating the thermal doctrine.
FDA/HHS do not complete a modern RF health-risk assessment.
And the public is told everything is fine.
That is not public-health protection.
That is preemption without protection.
What Must Happen Now
No FDA commissioner should move forward without answering these questions on the record:
Will FDA acknowledge that Public Law 90-602 applies to non-ionizing RF radiation from electronic products?
Will FDA conduct or commission a modern RF-EMF health-risk assessment that includes non-thermal endpoints, children, pregnancy, reproductive health, cancer, long-term exposure, modulation, pulsation, and aggregate exposure?
Will FDA formally advise the FCC in response to the D.C. Circuit remand?
Will FDA explain the NTP findings honestly instead of burying them behind generic reassurance language?
Will FDA restore or replace the abandoned federal RFR research program for modern 4G, 5G, Wi-Fi, wearables, beamforming, and 6G-relevant exposures?
Will FDA update public-facing safety statements so they distinguish between absence of conclusive proof and proof of safety?
Will HHS/FDA appoint real RF bioeffects, toxicology, pediatric, reproductive-health, oncology, dosimetry, and biomedical-device experts to an independent advisory panel?
Will Congress repeal or amend Section 704 so local governments are not silenced while federal limits remain legally remanded and medically outdated?
That is the confirmation test.
Not whether a nominee can manage agency politics.
Not whether a nominee has a polished résumé.
The test is whether the next commissioner will enforce the parts of FDA law that have been allowed to disappear while wireless exposure became a condition of modern life.
This Is Not Anti-Technology
The industry wants to frame every critic as anti-technology.
That is false.
This is not anti-technology. This is anti-denial.
Fiber is technology. Wired schools are technology. Shielded medical accommodations are technology. Li-Fi and optical wireless are technology. Better antennas, lower exposures, smarter defaults, and biology-based safety standards are technology.
The question is not whether we will have communications infrastructure.
The question is whether that infrastructure will be engineered around biological reality or around corporate convenience.
The thermal-only age is over.
The animal evidence is no longer dismissible. The court record is no longer dismissible. The TheraBionic precedent is no longer dismissible. The calcium-channel evidence is no longer dismissible. The genotype-dependent sleep-EEG data are no longer dismissible. The CYB5B calcium-oscillation evidence is no longer dismissible. The Melnick–Moskowitz risk assessment is no longer dismissible.
The regulators can keep pretending.
But the biology has moved on.
The law has already moved on.
The courts have already moved on.
Now public-health leadership must move on.
WHO and ICNIRP have spent too long protecting the old doctrine. The UK has spent too long repeating it. The FCC has spent too long hiding behind it. FDA has spent too long allowing it to stand.
President Trump was right to walk away from WHO’s failed global health model. Now HHS, FDA, Congress, and every nation still trapped inside the ICNIRP–WHO loop must finish the job.
No more thermal-only excuses.
No more insider reviews of insider guidelines.
No more telling suffering people their symptoms are real while refusing to build the science capable of finding out why.
No more preemption without protection.
Our children do not have another generation to donate to failed assumptions.
The science of denial ends when public health stops asking what is convenient for industry and starts asking what is true for biology.
